vs

Side-by-side financial comparison of Crown Castle (CCI) and Dexcom (DXCM). Click either name above to swap in a different company.

Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.0B, roughly 1.2× Crown Castle). Dexcom runs the higher net margin — 21.2% vs -45.9%, a 67.2% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs -4.8%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs -4.5%).

Crown Castle Inc. is a real estate investment trust and provider of shared communications infrastructure in the United States headquartered in Houston, Texas. Operating with 100 offices worldwide, its network includes over 40,000 cell towers and approximately 85,000 route miles of fiber supporting small cells and fiber systems.

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

CCI vs DXCM — Head-to-Head

Bigger by revenue
DXCM
DXCM
1.2× larger
DXCM
$1.3B
$1.0B
CCI
Growing faster (revenue YoY)
DXCM
DXCM
+26.4% gap
DXCM
21.6%
-4.8%
CCI
Higher net margin
DXCM
DXCM
67.2% more per $
DXCM
21.2%
-45.9%
CCI
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
-4.5%
CCI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CCI
CCI
DXCM
DXCM
Revenue
$1.0B
$1.3B
Net Profit
$-464.0M
$267.3M
Gross Margin
62.9%
Operating Margin
46.0%
25.6%
Net Margin
-45.9%
21.2%
Revenue YoY
-4.8%
21.6%
Net Profit YoY
153.6%
EPS (diluted)
$1.48
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCI
CCI
DXCM
DXCM
Q1 26
$1.0B
$1.3B
Q4 25
$1.1B
$1.3B
Q3 25
$1.1B
$1.2B
Q2 25
$1.1B
$1.2B
Q1 25
$1.1B
$1.0B
Q4 24
$1.1B
$1.1B
Q3 24
$1.1B
$994.2M
Q2 24
$1.1B
$1.0B
Net Profit
CCI
CCI
DXCM
DXCM
Q1 26
$-464.0M
$267.3M
Q4 25
$294.0M
$267.3M
Q3 25
$323.0M
$283.8M
Q2 25
$291.0M
$179.8M
Q1 25
$-464.0M
$105.4M
Q4 24
$151.7M
Q3 24
$303.0M
$134.6M
Q2 24
$251.0M
$143.5M
Gross Margin
CCI
CCI
DXCM
DXCM
Q1 26
62.9%
Q4 25
97.4%
62.9%
Q3 25
97.2%
60.5%
Q2 25
97.5%
59.5%
Q1 25
97.4%
56.9%
Q4 24
97.7%
58.9%
Q3 24
97.6%
59.7%
Q2 24
97.7%
62.4%
Operating Margin
CCI
CCI
DXCM
DXCM
Q1 26
46.0%
25.6%
Q4 25
48.8%
25.6%
Q3 25
49.0%
20.1%
Q2 25
47.7%
18.4%
Q1 25
49.1%
12.9%
Q4 24
51.0%
17.0%
Q3 24
47.5%
15.3%
Q2 24
44.7%
15.7%
Net Margin
CCI
CCI
DXCM
DXCM
Q1 26
-45.9%
21.2%
Q4 25
27.5%
21.2%
Q3 25
30.1%
23.5%
Q2 25
27.5%
15.5%
Q1 25
-43.7%
10.2%
Q4 24
13.6%
Q3 24
27.1%
13.5%
Q2 24
22.7%
14.3%
EPS (diluted)
CCI
CCI
DXCM
DXCM
Q1 26
$1.48
$0.67
Q4 25
$0.67
$0.67
Q3 25
$0.74
$0.70
Q2 25
$0.67
$0.45
Q1 25
$-1.07
$0.27
Q4 24
$0.37
Q3 24
$0.70
$0.34
Q2 24
$0.58
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCI
CCI
DXCM
DXCM
Cash + ST InvestmentsLiquidity on hand
$55.0M
$917.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
Total Assets
$31.4B
$6.3B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCI
CCI
DXCM
DXCM
Q1 26
$55.0M
$917.7M
Q4 25
$99.0M
$917.7M
Q3 25
$57.0M
$1.8B
Q2 25
$94.0M
$1.2B
Q1 25
$60.0M
$904.9M
Q4 24
$100.0M
$606.1M
Q3 24
$194.0M
$621.2M
Q2 24
$155.0M
$939.2M
Total Debt
CCI
CCI
DXCM
DXCM
Q1 26
Q4 25
$21.6B
Q3 25
$21.6B
Q2 25
$22.0B
Q1 25
$22.9B
Q4 24
$23.5B
Q3 24
$23.5B
Q2 24
$22.9B
Stockholders' Equity
CCI
CCI
DXCM
DXCM
Q1 26
$2.7B
Q4 25
$-1.6B
$2.7B
Q3 25
$-1.5B
$2.7B
Q2 25
$-1.4B
$2.6B
Q1 25
$-1.3B
$2.3B
Q4 24
$-133.0M
$2.1B
Q3 24
$5.3B
$2.0B
Q2 24
$5.7B
$2.4B
Total Assets
CCI
CCI
DXCM
DXCM
Q1 26
$31.4B
$6.3B
Q4 25
$31.5B
$6.3B
Q3 25
$31.5B
$7.5B
Q2 25
$31.6B
$7.3B
Q1 25
$31.8B
$6.8B
Q4 24
$32.7B
$6.5B
Q3 24
$38.0B
$6.4B
Q2 24
$38.2B
$6.8B
Debt / Equity
CCI
CCI
DXCM
DXCM
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
4.43×
Q2 24
4.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCI
CCI
DXCM
DXCM
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-43.0M
FCF MarginFCF / Revenue
-4.3%
Capex IntensityCapex / Revenue
1.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCI
CCI
DXCM
DXCM
Q1 26
Q4 25
$3.1B
$294.0M
Q3 25
$714.0M
$659.9M
Q2 25
$832.0M
$303.0M
Q1 25
$641.0M
$183.8M
Q4 24
$2.9B
$301.4M
Q3 24
$699.0M
$199.5M
Q2 24
$768.0M
$279.4M
Free Cash Flow
CCI
CCI
DXCM
DXCM
Q1 26
$-43.0M
Q4 25
$2.9B
$192.1M
Q3 25
$671.0M
$579.4M
Q2 25
$792.0M
$208.9M
Q1 25
$601.0M
$96.8M
Q4 24
$2.8B
$176.8M
Q3 24
$661.0M
$88.3M
Q2 24
$729.0M
$213.3M
FCF Margin
CCI
CCI
DXCM
DXCM
Q1 26
-4.3%
Q4 25
268.4%
15.3%
Q3 25
62.6%
47.9%
Q2 25
74.7%
18.1%
Q1 25
56.6%
9.3%
Q4 24
247.3%
15.9%
Q3 24
59.0%
8.9%
Q2 24
65.9%
21.2%
Capex Intensity
CCI
CCI
DXCM
DXCM
Q1 26
1.0%
Q4 25
17.0%
8.1%
Q3 25
4.0%
6.7%
Q2 25
3.8%
8.1%
Q1 25
3.8%
8.4%
Q4 24
15.7%
11.2%
Q3 24
3.4%
11.2%
Q2 24
3.5%
6.6%
Cash Conversion
CCI
CCI
DXCM
DXCM
Q1 26
Q4 25
10.40×
1.10×
Q3 25
2.21×
2.33×
Q2 25
2.86×
1.69×
Q1 25
1.74×
Q4 24
1.99×
Q3 24
2.31×
1.48×
Q2 24
3.06×
1.95×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCI
CCI

Site rental$961.0M95%
Services and other$49.0M5%

DXCM
DXCM

Segment breakdown not available.

Related Comparisons